Max S. Wicha
Directeur/Membre du Conseil chez Van Andel Institute
Profil
Max S.
Wicha is the founder of OncoMed Pharmaceuticals, Inc. He is currently a trustee at Van Andel Institute.
Postes actifs de Max S. Wicha
| Sociétés | Poste | Début |
|---|---|---|
Van Andel Institute
 Van Andel Institute Miscellaneous Commercial ServicesCommercial Services Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI. | Directeur/Membre du Conseil | - |
Anciens postes connus de Max S. Wicha
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Van Andel Institute
Van Andel Institute Miscellaneous Commercial ServicesCommercial Services Van Andel Institute provides biomedical research and education services. Its services include antibody production, spectral karyotyping, immunostaining and mouse modeling, animal imaging, computational biology, flow cytometry, germline modification and cytogenetics, mass spectrometry and proteomics, microarray technology, sequencing, vivarium, xenotransplantation and michigan animal consortium, as well as analytical, cellular and molecular microscopy services. The company was founded by Jay van Andel and Betty Van Andel in 1996 and is headquartered in Grand Rapids, MI. | Commercial Services |
